Schonfeld Strategic Advisors LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-08-14
4:31 pm
Purchase		2025-06-3013GMersana Therapeutics, Inc.
MRSN		Schonfeld Strategic Advisors LLC5,673,852
4.550%		5,369,289increase
(+1762.95%)		Filing
History
2025-08-14
4:31 pm
Sale		2025-06-3013GSkye Bioscience, Inc.
SKYE		Schonfeld Strategic Advisors LLC1,115,939
3.600%		-501,758decrease
(-31.02%)		Filing
History
2025-08-14
4:30 pm
Sale		2025-06-3013GFate Therapeutics, Inc.
FATE		Schonfeld Strategic Advisors LLC937,521
0.820%		-6,856,992decrease
(-87.97%)		Filing
History
2025-05-15
4:31 pm
Purchase		2025-03-3113GMersana Therapeutics, Inc.
MRSN		Schonfeld Strategic Advisors LLC304,563
6.110%		304,563increase
(New Position)		Filing
History
2025-05-15
4:31 pm
Sale		2025-03-3113GTerns Pharmaceuticals, Inc.
TERN		Schonfeld Strategic Advisors LLC4,305,204
4.930%		-929,304decrease
(-17.75%)		Filing
History
2025-05-15
4:31 pm
Purchase		2025-03-3113GSkye Bioscience, Inc.
SKYE		Schonfeld Strategic Advisors LLC1,617,697
5.220%		1,617,697increase
(New Position)		Filing
History
2025-05-15
4:30 pm
Purchase		2025-03-3113GFate Therapeutics, Inc.
FATE		Schonfeld Strategic Advisors LLC7,794,513
6.800%		7,794,513increase
(New Position)		Filing
History
2025-05-15
4:30 pm
Sale		2025-03-3113GApplied Therapeutics, Inc.
APLT		Schonfeld Strategic Advisors LLC4,676,097
3.300%		-4,093,543decrease
(-46.68%)		Filing
History
2025-02-14
4:16 pm
Sale		2024-12-3113GReviva Pharmaceuticals Holdings, Inc.
RVPH		Schonfeld Strategic Advisors LLC1,314,915
2.820%		-457,800decrease
(-25.82%)		Filing
History
2025-02-14
4:15 pm
Purchase		2024-12-3113GApplied Therapeutics, Inc.
APLT		Schonfeld Strategic Advisors LLC8,769,640
7.540%		8,769,640increase
(New Position)		Filing
History
2025-02-14
4:15 pm
Purchase		2024-12-3113GTerns Pharmaceuticals, Inc.
TERN		Schonfeld Strategic Advisors LLC5,234,508
6.160%		5,234,508increase
(New Position)		Filing
History
2024-11-14
4:15 pm
Purchase		2024-09-3013GReviva Pharmaceuticals Holdings, Inc.
RVPH		Schonfeld Strategic Advisors LLC1,772,715
5.300%		1,772,715increase
(New Position)		Filing
History
2024-02-14
4:31 pm
Sale		2023-12-3113GCyclacel Pharmaceuticals, Inc.
CYCC		Schonfeld Strategic Advisors LLC8
0.180%		-206decrease
(-96.30%)		Filing
History
2024-02-14
4:30 pm
Sale		2023-12-3113GGCM Grosvenor Inc.
GCMG		Schonfeld Strategic Advisors LLC41,993
0.100%		-3,546,723decrease
(-98.83%)		Filing
History
2023-02-14
4:32 pm
Sale		2022-12-3113GMarketWise, Inc.
MKTW		Schonfeld Strategic Advisors LLC0
0.000%		-73,445decrease
(Position Closed)		Filing
History
2023-02-14
4:31 pm
Purchase		2022-12-3113GCyclacel Pharmaceuticals, Inc.
CYCC		Schonfeld Strategic Advisors LLC214
6.140%		214increase
(New Position)		Filing
History
2023-02-14
4:30 pm
Sale		2022-12-3113GGCM Grosvenor Inc.
GCMG		Schonfeld Strategic Advisors LLC3,588,716
7.990%		-1,121,757decrease
(-23.81%)		Filing
History
2022-06-09
4:45 pm
Purchase		2022-05-3113GGCM Grosvenor Inc.
GCMG		Schonfeld Strategic Advisors LLC4,710,473
10.500%		2,086,113increase
(+79.49%)		Filing
History
2022-02-15
4:07 pm
Purchase		2021-12-3113GMarketWise, Inc.
MKTW		Schonfeld Strategic Advisors LLC73,445
5.840%		73,445increase
(New Position)		Filing
History
2022-02-14
11:36 am
Purchase		2021-12-3113GGCM Grosvenor Inc.
GCMG		Schonfeld Strategic Advisors LLC2,624,360
6.000%		2,624,360increase
(New Position)		Filing
History
Goto 0, 1, Next